MXCT vs ROK · rev $38.6M vs P/E 48, rev $8.34B
MaxCyte Inc (MXCT) versus Rockwell Automation Inc (ROK) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Rockwell Automation Inc (ROK) is a specialty industrial machinery company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported ROK revenue for 2025-09-30 was $8.34B. Net income was $749.0M. Revenue was up 0.9% from 2024-09-30 to 2025-09-30. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
MXCT currently screens at market cap $124.3M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
Not investment advice. Open the MXCT and ROK stock pages for the full models.
Not investment advice.